Cargando…

Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients

BACKGROUND: Less than 20 % of patients with resectable oesophageal adenocarcinoma obtain a pathological response following neoadjuvant chemotherapy. Studies using oesophageal cancer cell lines have shown that drug sensitive tumour cells undergo apoptosis in response to drug treatment, whereas resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Mashed, Shereen, O’Donovan, Tracey R., Kay, Elaine, O’Grady, Anthony, McManus, Damian, Turkington, Richard C., McKenna, Sharon L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392302/ https://www.ncbi.nlm.nih.gov/pubmed/35986318 http://dx.doi.org/10.1186/s12885-022-09981-8

Ejemplares similares

UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells
por: Falvey, Chloe M., et al.
Publicado: (2017)

Correction: UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells
por: Falvey, Chloe M., et al.
Publicado: (2020)

LC3B globular structures correlate with survival in esophageal adenocarcinoma
por: El-Mashed, Shereen, et al.
Publicado: (2015)

Correction to: LC3B globular structures correlate with survival in esophageal adenocarcinoma
por: El-Mashed, Shereen, et al.
Publicado: (2019)

MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells
por: Nyhan, Michelle J., et al.
Publicado: (2016)

Alterations in the Ca(2+) toolkit in oesophageal adenocarcinoma
por: Cutliffe, Alana L., et al.
Publicado: (2021)

Curcumin induces apoptosis-independent death in oesophageal cancer cells
por: O'Sullivan-Coyne, G, et al.
Publicado: (2009)

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells
por: Nyhan, M J, et al.
Publicado: (2012)

Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo
por: O’Donovan, Tracey R., et al.
Publicado: (2015)

Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer
por: Lavery, Anita, et al.
Publicado: (2021)

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study
por: McCain, Stephen, et al.
Publicado: (2018)

Electrochemotherapy Causes Caspase-Independent Necrotic-Like Death in Pancreatic Cancer Cells
por: Fernandes, Philana, et al.
Publicado: (2019)

All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism
por: Benjamin, Dalyia N., et al.
Publicado: (2022)

The changing face of oesophageal cancer treatment in Northern Ireland.
por: McManus, K., et al.
Publicado: (1994)

VHL Genetic Alteration in CCRCC Does Not Determine De-Regulation of HIF, CAIX, hnRNP A2/B1 and Osteopontin
por: Nyhan, Michelle J., et al.
Publicado: (2010)

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
por: Humphries, Matthew P., et al.
Publicado: (2020)

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma
por: Blayney, Jaine K., et al.
Publicado: (2018)

Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma
por: Jiang, William, et al.
Publicado: (2022)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
por: Turkington, Richard C, et al.
Publicado: (2019)

Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA‐induced differentiation of leukemic cells
por: Orfali, Nina, et al.
Publicado: (2020)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Barrett’s Esophagus and Esophagogastric Cancer
por: Turkington, Richard C., et al.
Publicado: (2021)

Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023)

A non-endoscopic device to sample the oesophageal microbiota: a case-control study
por: Elliott, Daffolyn R Fels, et al.
Publicado: (2016)

Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten‐free diet
por: O'Morain, Neil, et al.
Publicado: (2021)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study
por: McMenamin, Úna C., et al.
Publicado: (2018)

Oesophageal adenocarcinoma: In the era of extended lymphadenectomy, is the value of neoadjuvant therapy being attenuated?
por: Park, Jin-Soo, et al.
Publicado: (2021)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
por: M. Naeini, Marjan, et al.
Publicado: (2023)

A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma
por: Ryan, B M, et al.
Publicado: (2001)

High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancer
por: Fitzgerald, Seán, et al.
Publicado: (2014)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
por: Powell, A. G. M. T., et al.
Publicado: (2020)

Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma
por: Powell, A. G. M. T., et al.
Publicado: (2020)

Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance
por: Graham Martinez, Cristina, et al.
Publicado: (2022)

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: Hagens, E. R. C., et al.
Publicado: (2020)

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
por: Davern, Maria, et al.
Publicado: (2022)

Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy
por: Yoshikawa, R, et al.
Publicado: (2008)

Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy
por: Knight, W. R. C., et al.
Publicado: (2018)

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer
por: Vollenbrock, S. E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hbi5sbi46vair11000r8773uvi